2010
DOI: 10.2471/blt.09.068080
|View full text |Cite
|
Sign up to set email alerts
|

Vitamin A supplementation and neonatal mortality in the developing world: a meta-regression of cluster-randomized trials

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
21
0
1

Year Published

2010
2010
2018
2018

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(23 citation statements)
references
References 31 publications
1
21
0
1
Order By: Relevance
“…The heterogeneity of the population included in these trials might explain these controversial results [31,32]. Indeed, a linear relationship between the prevalence of VAD in pregnant women and the observed effectiveness of VAS at birth has been suggested [31]. VAS might reduce infant mortality only in regions where its deficiency is more common.…”
Section: Vitamin a Supplementation In Pregnant Women Or Postpartum Momentioning
confidence: 97%
See 1 more Smart Citation
“…The heterogeneity of the population included in these trials might explain these controversial results [31,32]. Indeed, a linear relationship between the prevalence of VAD in pregnant women and the observed effectiveness of VAS at birth has been suggested [31]. VAS might reduce infant mortality only in regions where its deficiency is more common.…”
Section: Vitamin a Supplementation In Pregnant Women Or Postpartum Momentioning
confidence: 97%
“…However, all subsequent RCT highlighted the lack of benefit of maternal VAS on miscarriage, maternal or infant mortality and morbidity [24,26 && , 27-29,30 && ]. The heterogeneity of the population included in these trials might explain these controversial results [31,32]. Indeed, a linear relationship between the prevalence of VAD in pregnant women and the observed effectiveness of VAS at birth has been suggested [31].…”
Section: Vitamin a Supplementation In Pregnant Women Or Postpartum Momentioning
confidence: 98%
“…The World Health Organization (WHO) has recommended vitamin A supplementation of 100,000–200,000 IU every 4 to 6 months to increase its levels in VAD infants and children. Supplementation of large dose vitamin A (with or w/o vaccination) in randomized placebo controlled clinical trials in VAD regions suggests an overall positive effect on infection-related morbidity and mortality, varying however, with pathogen, age and gender (711). …”
Section: Introductionmentioning
confidence: 99%
“…Rotondi and Khobzi (2010) reffered that the relation between the prevalence of vitamin A deficiency in pregnant and the effect of neonatal vitamin A supplementation on infant mortality [18]. Rondò et al (2001) referred that the Concentrations of vitamin A in cord blood correlated significantly with birth weight and length [19].…”
Section: Discussionmentioning
confidence: 99%